|
|
Clinical effects of self-made Qingyu Hejiang Decoction in treating patients with liver and stomach stagnation-heat type of reflux esophagitis |
LIU Jie ZHU Qi CHEN Xin BAI Shaoyu REN Dengjie |
Department of Integrated Traditional Chinese Medicine and Western Medicine, Zigong First People’s Hospital, Sichuan Province, Zigong 643000, China
|
|
|
Abstract Objective To investigate the clinical effects of self-made Qingyu Hejiang Decoction Tang in treating patients with liver and stomach stagnation-heat type of reflux esophagitis (RE). Methods Ninety-eight cases of RE patients admitted to Zigong First People’s Hospital, Sichuan Province from January 2021 to April 2022 were selected and divided into control and observation groups using the random number table method, with 49 cases in each group. The control group was treated with conventional western medicine, while the observation group was treated with the addition of self-made Qing Yu and Hejiang Decoction. Both groups were treated with 14 d as a course of treatment, and a total of three courses of treatment were given. The efficacy of the two groups was compared, the traditional Chinese medicine symptom score and esophageal kinetics before and after treatment in both groups, and the occurrence of adverse reactions was recorded. Results After the treatment, the points of acid reflux and heartburn, abdominal distension and fullness, belching and early satiety, loss of appetite, and red tongue with yellow coating in both groups were lower than those before treatment, while those in the observation group were lower than those in the control group, and the differences were statistically significant (P<0.05). After treatment, the esophageal sphincter pressure, lower esophageal sphincter pressure, and distal esophageal contraction points in both groups were higher than before treatment, while those in the observation group were higher than those in the control group, and the differences were statistically significant (P<0.05). The clinical efficacy of the observation group was better than that of the control group, and the difference was statistically significant (P<0.05). The difference was not statistically significant when comparing the total incidence rate during treatment between the two groups (P>0.05). Conclusion The self-made Qingyu Hejiang Decoction is effective in treating RE with liver and stomach stagnation and heat, and can effectively improve clinical symptoms and esophageal dynamics with high safety.
|
|
|
|
|
[1] 赵本田,蒋海涛,王玲,等.典型症状与非典型症状胃食管反流病患者食管动力及反流特点临床研究[J].中国全科医学,2020,23(15):1904-1909.
[2] 赵晓晓,谢佳平,赵景润,等.复发性反流性食管炎内镜特征的临床对比研究[J].中华消化内镜杂志,2020,37(1):45-47.
[3] 徐阳,唐艳萍.难治性反流性食管炎的病因及诊治研究进展[J].中国中西医结合外科杂志,2020,26(1):183-186.
[4] 李勉力,张伟健,郭玲珑,等.沃诺拉赞对比质子泵抑制剂治疗反流性食管炎有效性和安全性的Meta分析[J].中国全科医学,2021,24(6):611-616.
[5] 李美荣,王晓伟,牛美娜,等.雷贝拉唑,莫沙必利联合米曲菌胰酶治疗反流性食管炎伴功能性消化不良的疗效[J].中国新药与临床杂志,2021,40(7):295-299.
[6] 张丽丽,李婉如,刘梦欢,等.中医“和法”结合针刺疗法治疗反流性食管炎肝胃不和型疗效及对胃肠激素的影响[J].现代中西医结合杂志,2022,31(11):1492-1496.
[7] 孟丹,蒋勇前,徐传藩,等.清郁和降汤联合奥美拉唑对支气管哮喘合并胃食管反流病患者气道炎症的影响[J].世界中西医结合杂志,2021,16(2):355-358.
[8] 中华医学会消化内镜学分会.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222.
[9] 中华中医药学会脾胃病分会.胃食管反流病中医诊疗专家共识意见(2017)[J].中国中西医结合消化杂志,2017, 25(5):321-326.
[10] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,2012:214-215.
[11] 中国中西医结合学会消化系统疾病专业委员会.胃食管反流病中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(3):221-226,232.
[12] 刘思雨,唐艳萍,刘磊,等.基于蛋白组学和NCBI数据库探究反流性食管炎及细胞焦亡调控基因[J].中华实验外科杂志,2022,39(4):676-678.
[13] 高慧.盐酸伊托必利,法莫替丁,奥美拉唑三联治疗反流性食管炎患者的效果[J].中国民康医学,2020,32(22):14-16.
[14] 韦月辽,杨锐,梁小群,等.莫沙必利对胃食管反流病患者食管动力的影响[J].现代消化及介入诊疗,2022,27(3):347-350.
[15] 樊帅珂,方晓艳,朱正望,等.基于中西医临床病症特点的反流性食管炎动物模型分析[J].中国中医基础医学杂志,2021,27(9):282-285.
[16] 赵旦娅,郁宏文,陆为民.国医大师徐景藩从肺,胃,肝论治反流性食管炎经验[J].中华中医药杂志,2021,36(5):2709-2711.
[17] 彭艳红,吴东宁,滕丹,等.基于生物信息学的疏肝利胆和胃方组方特点及治疗反流性食管炎机制分析[J].中国中医药信息杂志,2020,27(7):103-109.
[18] 赵岩,孙雪松,陈冬梅. 清郁和降汤联合雷贝拉唑钠肠溶胶囊对支气管哮喘合并胃食管反流病患者气道炎症的影响[J].现代中西医结合杂志,2020,29(26):2953-2956.
[19] 应笑,李蒙,金超琼,等.基于里昂共识比较胃食管反流病与食管功能性疾病的食管动力学差异[J].中华消化杂志,2020,40(2):87-92.
[20] 唐海雯,游庆霞,张晨,等.加味桔梗枳壳汤治疗胃食管反流病临床研究[J].湖北中医药大学学报,2021,23(5):80-83.
[21] 刘磊,唐艳萍,弓艳霞,等.活血通降方对反流性食管炎大鼠食管黏膜NF-κB/MAPK信号转导通路的影响[J].中国中西医结合外科杂志,2021,27(4):555-562.
[22] 田山,郭绪峰,郭颖韵,等.热休克蛋白47与消化系统肿瘤的研究进展[J].临床内科杂志,2021,38(10):713-715.
[23] Villa-Roel N,Ryu K,Gu L,et al. Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice [J]. Atherosclerosis,2022,34(4):20-30.
[24] 陈静,曹正民,徐蕾,等.中医药治疗反流性食管炎作用机制研究进展[J].中华中医药学刊,2022,40(7):177-181.
[25] 陈霞,石益海,朱婵艳,等.自拟和中健脾汤结合西医常规疗法对反流性食管炎患者胃肠动力学及炎性细胞因子水平的影响[J].国际中医中药杂志,2020,42(3):213- 216. |
|
|
|